At a $315M market cap trading at 18.9x earnings but only 3.8x forward earnings, the market is clearly pricing in either a sharp earnings rebound or a distorted forward estimate—yet the collapse from $2.7 EPS to an estimated $0.90 next year contradicts that optimism. A Price/Book of 1 suggests asset-level support, but the 1.1 Altman Z-Score is flashing financial distress risk, not stability. The 22.00% ROE looks impressive on the surface, yet it is paired with a razor-thin 4.50% operating margin and 3.30 Debt/Equity, indicating leverage is doing much of the work. This is not a clean GARP setup; it is a leveraged commodity play where solvency risk and earnings volatility dominate the narrative.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.